Published in Vaccine Weekly, October 8th, 2008
The scientific review analyzed outcomes from in vivo studies evaluating the effect of AHCC supplementation on immune response following challenge with a variety of infectious agents such as the influenza (flu) virus, avian influenza (bird flu), Methicillin-Resistant Staphylococcus aureus (MRSA), Klebsiella pnuemoniae and Candida albicans. It was reported that supplementation with AHCC modulated immunity and delivered positive...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2008-10-08)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.